Registry of Lobbyists

Registration - Consultant

WISCONSIN PHARMACAL CO.INC. / ANDREW JONES, Consultant

Registration Information

Client name: WISCONSIN PHARMACAL CO.INC.
Lobbyist name: ANDREW JONES, Consultant
Initial registration start date: 1996-12-04
Registration status: Inactive
Registration Number: 779841-7146

Version 1 of 1 (1996-12-04 to 1998-05-15)

Version 1 of 1 (1996-12-04 to 1998-05-15) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Registrant

Consultant lobbyist name: ANDREW JONES    Lobbyist business address
Consulting firm: SAMCI (S.A. MURRAY CONSULTING INC.)
81 METCALFE STREET, 10TH FLOOR
OTTAWA, ON  K1P 6K7
Canada
Position: RESEARCH
Telephone number: 613-236-3383  
Fax number: 613-236-4184  
 
Former public office holder: N/A. Disclosure of this information was not a requirement prior to June 20, 2005.
Payment is contingent on the success of the undertaking: No

B. Information about Client

Client: WISCONSIN PHARMACAL CO.INC.
1 REPEL ROAD
JACKSON, WI  53037
United States of America
Telephone number: 414-677-4121  Ext.: 0
Fax number: 414-677-9006  
 
Client Representative: MARY CONRARDY
 
Parent: The client is not a subsidiary of any other parent companies.
Coalition: The client is not a coalition.
Subsidiary: The client does not have any subsidiaries that could be affected by the outcome of the undertaking.
Individual, organization or corporation: The client's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
 
Was the client funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

C. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Industry Canada
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Informal communications, Meetings, Telephone calls, Written communications, whether in hard copy or electronic format
 
Subject Matter: Areas of Concern: Health
 

Details Regarding the Identified Subject Matter

Categories Description
Regulation PROVIDE ASSISTANCE FOR PRODUCT APPROVAL AT HEALTH CANADA-PEST MANAGEMENT REVIEW AGENCY




Date Modified: